Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.
Clinical trial NCT07243002 · RECRUITING
Trial details
- NCT number
- NCT07243002
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-15
- Primary completion
- 2030-04-30
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.